The New York-based mental health company also announced a measurement-informed system to help providers transition to value-based care.
The feature provides vibrotactile stimulation when a patient is experiencing freezing of gait, a common symptom of Parkinson's disease.
The company is launching Osso Health, a medical training app with workflows for common procedures hosted on Apple's augmented reality headset.
Augmedix's AI-enabled ambient automation will be integrated into Andor Health’s AI virtual consultation platform, ThinkAndor.
The companies plan to reduce burnout and support diagnosis efficiency through new AI-powered applications.
Clinical-trial research company Clario announces new hire, and AI-enabled surgical care organization Apella and data company Brillio announce additions to their board of directors.
The companies' joint offering, ThinkSono Guidance, attained Class IIb CE mark approval in March with upcoming plans for FDA approval.
Stock exchange rules give Amwell six months to comply with its minimum price requirement of $1 per share or be delisted. Amwell last traded above $1 in March.
The partnership seeks to close the recovery gap between hospital and at-home care by offering in-home follow-up appointments.
The partnership will expand cardiovascular care to areas without specialized infrastructure like CT imaging.
